Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-17-000320
Filing Date
2017-03-29
Accepted
2017-03-28 18:17:30
Documents
2
Group Members
ROSALIND ADVISORS, INC.ROSALIND CAPITAL PARTNERS L.P.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zosano_13ga1.htm SC 13G/A 136088
2 EXHIBIT A ex_a.htm EX-99.A 9357
  Complete submission text file 0001019056-17-000320.txt   147167
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Subject) CIK: 0001587221 (see all company filings)

EIN.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88596 | Film No.: 17720217
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: SC 13G/A